<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Congenital <z:e sem="disease" ids="C0015503" disease_type="Disease or Syndrome" abbrv="">factor VII deficiency</z:e> is a rare (1:500,000) autosomally recessive <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> with variable expression and high penetration </plain></SENT>
<SENT sid="1" pm="."><plain>In infants the most devastating presentation is that of intracranial haemorrhage </plain></SENT>
<SENT sid="2" pm="."><plain>An infant is described with severe <z:e sem="disease" ids="C0015503" disease_type="Disease or Syndrome" abbrv="">factor VII deficiency</z:e> who developed postnatal intracranial haemorrhage </plain></SENT>
<SENT sid="3" pm="."><plain>The baby was treated with factor VII concentrate (ImmunoA.G., Vienna, Austria) </plain></SENT>
<SENT sid="4" pm="."><plain>Three weeks after the haemorrhage he developed a dural venous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Although factor VII-deficient patients may need treatment with factor VII concentrate, this needs to be carefully monitored because of the thrombotic risk </plain></SENT>
</text></document>